SOPHARMA (SPH) Raporty ESPI/EBI
- 25.04.2024 13:31 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (22/2024) Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format
- 22.04.2024 13:06 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (21/2024) Sales revenues of Sopharma AD for March 2024
- 01.04.2024 12:25 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (20/2024) Presentation of the Annual Audited Individual Financial Statements of "Sopharma" AD as at 31 December 2022
- 20.03.2024 15:30 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (19/2024) Sales revenues for February 2024
- 12.03.2024 16:03 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (18/2024) Incoming transfer from capital increase subject to exercise of warrants from issue BG9200001212
- 11.03.2024 13:57 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (17/2024) Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase
- 29.02.2024 13:31 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (16/2024) Consolidated financial report as of 31 December 2023
- 27.02.2024 13:10 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (15/2024) Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
- 22.02.2024 10:50 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (14/2024) Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants
- 22.02.2024 10:46 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (13/2024) Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition
-
- 20.02.2024 15:20 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (12/2024) NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014 for subscribin shares from a temporary issue/exercising warrants
- 20.02.2024 15:16 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (11/2024) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 as of 20 February 2024 re exercising warrants
- 20.02.2024 11:07 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (10/2024) Notification from Ognian Donev under Art. 19 of Regulation (EU) 596/2014 for subscribing sharesd form a temporary issue/exercising warrants on 19 February 2024
- 20.02.2024 11:03 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (9/2024) Notification from Ognian Donev in accordance with art. 19 from Regulation 596/2014 for exercising warrants on 19 February 2024
- 19.02.2024 13:05 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (8/2024) Notification for Sales revenues for January 2024
- 31.01.2024 14:09 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (7/2024) Technical error in the Notification under Art. 89t of the Law on Public Offering of Securities published on 26.01.2024
- 30.01.2024 13:35 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (6/2024) Individual financial report according to IFRS as of 31 December 2023
- 26.01.2024 14:18 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (5/2024) Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exer
- 26.01.2024 13:45 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (4/2024) Sopharma AD-Sofia presented inutes of the General Meeting of Warrant Holders held on 26-01-2024 11:00 a.m
- 22.01.2024 13:05 Raport ESPI SOPHARMA (SPH): SOPHARMA AD (3/2024) Sales revenues for December 2023